MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Leveraging a Smartphone-based Platform for Parkinson’s disease Real-world Research: A Multicenter, Cross-sectional Feasibility Assessment Study

Z. Xu, Y. Tang, J. Wang (Shanghai, China)

Meeting: 2025 International Congress

Keywords: Parkinson’s

Category: Telemedicine

Objective: ​​​​​To evaluate the feasibility of a smartphone-based platform for remote patient-reported outcome (PRO) collection in Parkinson’s disease (PD) and explore its utility in identifying clinical characteristics (i.e., sex differences) in real-world settings.

Background: Mobile health (mHealth) platforms offer transformative advantages for PD real-world research, including real-time symptom tracking, reduced geographic barriers, and continuous patient engagement. However, the feasibility of such platforms in PD populations remains understudied.

Method: We have previously developed ‘PaWei’, a PD management smartphone app. with more than 15,000 users from 126 hospitals in mainland China. The app. has been listed in Movement Disorder Society (MDS) Digital App Repository. The platform enabled remote self-reporting of motor/non-motor symptoms, quality of life, and medication via questionnaires and validated rating scales. Data of 1,828 validated PD patients (1,001 male, 827 female) were analyzed to explore sex differences in self-reported clinical characteristics.

Results: The platform demonstrated robust feasibility in collecting data from geographically diverse PD patients across mainland China, including older adults with a mean age of 61 years. Secure data transmission and storage were maintained throughout the study. Secondary sex-based analyses identified notable disparities, such as a higher prevalence (p<0.001) of depression among females.

Conclusion: This study validates the feasibility of a smartphone-based platform for large-scale PRO collection in PD, offering a scalable solution for PD real-world research. Sex differences in clinical characteristics were identified based on app. data. The platform’s success in real-world settings underscores its potential to support longitudinal monitoring, personalized interventions, and inclusive research, particularly in underserved regions.

Figure 1

Figure 1

Figure 2

Figure 2

Figure 3

Figure 3

To cite this abstract in AMA style:

Z. Xu, Y. Tang, J. Wang. Leveraging a Smartphone-based Platform for Parkinson’s disease Real-world Research: A Multicenter, Cross-sectional Feasibility Assessment Study [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/leveraging-a-smartphone-based-platform-for-parkinsons-disease-real-world-research-a-multicenter-cross-sectional-feasibility-assessment-study/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/leveraging-a-smartphone-based-platform-for-parkinsons-disease-real-world-research-a-multicenter-cross-sectional-feasibility-assessment-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley